HOME >> BIOLOGY >> NEWS
Perfect Powders For Improved Implants

Biomedical implants, sporting goods and firearm parts can now be made using perfectly spherical particles of titanium produced by a breakthrough technique developed in Canada. This new technique will allow manufacturers to produce bone replacements that actively encourage the natural bone around them to grow, pacemaker filters and intricate firearm and watch parts.

The process, called Plasma Atomisation Technology (PAT), produces spherical titanium powders in three broad size ranges by melting titanium wire using a plasma torch, forming a spray and cooling the tiny droplets once they have formed into spheres. By using spheres instead of the angular irregularly shaped powders produced by other techniques, manufacturers can accurately spray the titanium balls onto a surface to give a coherent coating or pack them in tightly to a mould to prevent the final product from shrinking once heated.

The largest spheres can be used to coat implants, giving a porous network that actively encourages bone re-growth so strengthening the bond between the implant and natural bone. The smaller particles can be used for spraying as thin films or for pressing into intricate components such as the filters used in pacemakers. As the titanium powders are spherical the material is less likely to pick up too many contaminants in the production process resulting in a high quality end product.

PLEASE MENTION MATERIALS WORLD AS THE SOURCE OF THIS ITEM


'"/>

Contact: Andrew McLaughlin
Andrew_Mclaughlin@materials.org.uk
+ 44 (0)171 451 7395
Institute of Materials
1-Oct-1998


Page: 1

Related biology news :

1. Perfect planet, clever species
2. New Test Spots ALD Carriers With Near-Perfect Accuracy
3. Scientists Sift Through Trash In Search Of Perfect Landfill
4. Improved nutrition could reduce malaria burden worldwide
5. Improved nutrition could prevent more than half of the worlds child deaths annually
6. Improved crop production and fewer greenhouse gases
7. Improved medical treatment of serious heart problems focus of UH-led group
8. Improved estimates of population extinction risk (Harding and McNamara)
9. Improved guidance systems for missiles will reduce collateral damage
10. Bone Marrow Transplants May Be Improved Thanks To Discovery Of Mechanism Underlying Human Stem Cell Migration
11. Virginia Tech Research Group Presents Improved Dental Materials

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the ... offering. ... report provides separate comprehensive analytics for the US, Japan ... Annual estimates and forecasts are provided for the period 2015 through ... Market data and analytics are derived from primary and secondary research. ...
(Date:2/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) ... oral peptide drug candidates, PTG-100 and PTG-200, at ... Crohn,s and Colitis Organization (ECCO).  The ECCO congress ... from February 15 – 18, 2017. ... on Protagonist drug candidates PTG-100 and PTG-200. PTG-100, ...
(Date:2/16/2017)... BEACH, Fla. , Feb. 16, 2017 /PRNewswire/ ... company revolutionizing the development of liquid biopsy tests ... has entered into an exclusive license agreement with ... distribute MDNA,s proprietary liquid biopsy test for prostate ... South Korea . This is the ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology:
Cached News: